Obesity is associated with an increased risk of VTE, and it has been postulated that standard prophylactic LMWH doses may be insufficient to prevent VTE or achieve suggested anti-factor Xa target ...
Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic ... treatment of established DVT with or without PE is 175 anti-factor Xa IU per kilogram of body weight administered ...
Low molecular weight heparin (LMWH) is an anticoagulant injected subcutaneously or intravenously and acts via activation of antithrombin III which in turn inactivates thrombin and factor Xa to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback